BioStem Tech (BSEM)
BioStem Technologies, Inc. engages in the development, manufacturing, and commercialization of placental-derived allografts for advanced wound care and regenera...
- Open
- 3.630
- High
- 3.850
- Low
- 3.590
- Prev. Close
- 3.610
- Volume
- 87.49K
- Turnover
- 324.78K
- Avg Price
- 3.712
- Bid/Ask Ratio
- --
- Amplitude
- 7.20%
- 52wk High
- 4.660
- Volume Ratio
- 0.00
- Turnover Ratio
- 0.62%
BioStem Tech Analyst Rating
View moreForecast & Rating
Aug 24, 2026Price forecast
$7.0088.68%
Forecast & RatingStrong buy
1analysts
- Strong buy100.00%
- Buy0.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
News
- StockTitan · 1 day ago, 03:00 AM
BioStem Technologies Opens Hospital Access for VENDAJE® and VENDAJE AC® Through Vizient and Premier | BSEM Stock News
- Market Beat · Aug 22 at 01:01 AM
BioStem Technologies Eyes Surgical Growth, Manufacturing Shift After BioTissue Deal
- Quartr · Aug 19 at 01:28 PM
BSEM: Expanding hospital market access and clinical portfolio drive growth and profitability
